| Role of Toll‐like receptors in the pathogenesis of COVID‐19 S Khanmohammadi, N Rezaei Journal of medical virology 93 (5), 2735-2739, 2021 | 309 | 2021 |
| Pathologic features of COVID-19: A concise review M Tabary, S Khanmohammadi, F Araghi, S Dadkhahfar, SM Tavangar Pathology-Research and Practice 216 (9), 153097, 2020 | 138 | 2020 |
| Global, regional, and national prevalence and mortality burden of sickle cell disease, 2000–2021: a systematic analysis from the Global Burden of Disease Study 2021 AM Thomson, TA McHugh, AP Oron, C Teply, N Lonberg, VV Tella, ... The Lancet Haematology 10 (8), e585-e599, 2023 | 104 | 2023 |
| Global burden of cardiovascular diseases and risks, 1990-2022 GA Mensah, V Fuster, CJL Murray, GA Roth, ... Journal of the American College of Cardiology 82 (25), 2350-2473, 2023 | 95 | 2023 |
| A case of autosomal recessive interferon alpha/beta receptor alpha chain (IFNAR1) deficiency with severe COVID-19 S Khanmohammadi, N Rezaei, M Khazaei, A Shirkani Journal of clinical immunology, 1-6, 2022 | 54 | 2022 |
| Toll-like receptors and metabolic (dysfunction)-associated fatty liver disease S Khanmohammadi, MS Kuchay Pharmacological Research 185, 106507, 2022 | 43 | 2022 |
| Global age-sex-specific mortality, life expectancy, and population estimates in 204 countries and territories and 811 subnational locations, 1950–2021, and the impact of the … AE Schumacher, HH Kyu, A Aali, C Abbafati, J Abbas, ... The Lancet 403 (10440), 1989-2056, 2024 | 37 | 2024 |
| Global, regional, and national burden of disorders affecting the nervous system, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021 JD Steinmetz, KM Seeher, N Schiess, E Nichols, B Cao, C Servili, ... The Lancet Neurology 23 (4), 344-381, 2024 | 35 | 2024 |
| Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the … M Naghavi, KL Ong, A Aali, HS Ababneh, YH Abate, C Abbafati, ... The Lancet 403 (10440), 2100-2132, 2024 | 34 | 2024 |
| Triglyceride-glucose index and heart failure: a systematic review and meta-analysis A Khalaji, AH Behnoush, S Khanmohammadi, K Ghanbari Mardasi, ... Cardiovascular Diabetology 22 (1), 244, 2023 | 26 | 2023 |
| Lymphoma in the setting of autoimmune diseases: A review of association and mechanisms S Khanmohammadi, M Shabani, M Tabary, E Rayzan, N Rezaei Critical Reviews in Oncology/Hematology 150, 102945, 2020 | 24 | 2020 |
| Association of lipid accumulation product with type 2 diabetes mellitus, hypertension, and mortality: a systematic review and meta-analysis S Khanmohammadi, H Tavolinejad, A Aminorroaya, Y Rezaie, H Ashraf, ... Journal of Diabetes & Metabolic Disorders, 1-31, 2022 | 14 | 2022 |
| Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in … AJ Ferrari, DF Santomauro, A Aali, YH Abate, C Abbafati, H Abbastabar, ... The Lancet 403 (10440), 2133-2161, 2024 | 12 | 2024 |
| B-and T-cell Subset Abnormalities in Monogenic Common Variable Immunodeficiency S Fekrvand, S Khanmohammadi, H Abolhassani, R Yazdani Frontiers in Immunology, 2835, 2022 | 12 | 2022 |
| Genetic basis of Guillain-Barre syndrome S Khanmohammadi, M Malekpour, P Jabbari, N Rezaei Journal of Neuroimmunology 358, 577651, 2021 | 12 | 2021 |
| Endocan in prediabetes, diabetes, and diabetes-related complications: a systematic review and meta-analysis A Khalaji, AH Behnoush, B Saeedian, S Khanmohammadi, ... Diabetology & Metabolic Syndrome 15 (1), 102, 2023 | 10 | 2023 |
| Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease … M Brauer, GA Roth, AY Aravkin, P Zheng, KH Abate, YH Abate, C Abbafati, ... The Lancet 403 (10440), 2162-2203, 2024 | 9 | 2024 |
| Global fertility in 204 countries and territories, 1950–2021, with forecasts to 2100: a comprehensive demographic analysis for the Global Burden of Disease Study 2021 NV Bhattacharjee, AE Schumacher, A Aali, YH Abate, R Abbasgholizadeh, ... The Lancet 403 (10440), 2057-2099, 2024 | 7 | 2024 |
| COVID‐19 as a trigger of Guillain‐Barré syndrome: A review of the molecular mechanism M Malekpour, S Khanmohammadi, MJE Meybodi, D Shekouh, ... Immunity, inflammation and disease 11 (5), e875, 2023 | 7 | 2023 |
| Burden of Tracheal, Bronchus, and Lung Cancer in North African and Middle East countries, 1990 to 2019: Results from the GBD Study 2019 S Khanmohammadi, SS Moghaddam, S Azadnajafabad, N Rezaei, ... Frontiers in Oncology 12, 7500, 2023 | 7 | 2023 |
Nima RezaeiTehran University of Medical Sciences; Universal Scientific Education and Research Network (USERN)在 tums.ac.ir 的电子邮件经过验证
